Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system

https://doi.org/10.1016/0378-5173(92)90340-8Get rights and content

Abstract

The influence of a mucoadhesive polymer (Carbopol 1342) on the in-vitro release and in-vivo ocular bioavailability of pilocarpine nitrate entrapped in liposomes has been investigated. Coating of reverse phase evaporation vesicles (REVs) by Carbopol 1342 was achieved by incubating pre-formed vesicles in a 0.05% pH 5.0 polymer solution for 5 min. The in-vitro release phase of pilocarpine was extended by the presence of the polymer coating. The adsorbed film was therefore shown to provide a substantial barrier to drug release. Bioavailability was evaluated in albino rabbits by measuring the intensity and duration of the miotic response. Carbopol 1342 coated REVs showed a larger area under the miotic intensity curve (AUC) and a longer duration of action compared to uncoated REVs. No significant difference of area under the miotic intensity curve and duration of action was found between coated REVs and phosphate-buffered saline (PBS) solution containing the same concentration (0.5% w/v) of pilocarpine nitrate.

References (22)

  • S. Benita et al.

    Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye

    J. Microencapsulation

    (1984)
  • Cited by (62)

    • Polymeric and lipid nanocarriers in glaucoma

      2023, Nanotechnology in Ophthalmology
    • How liposomes pave the way for ocular drug delivery after topical administration

      2022, Journal of Drug Delivery Science and Technology
      Citation Excerpt :

      Negative or neutral liposomes cannot be significantly useful unless they bear functional groups through which they can react with the eye's surface and show the mucoadhesive characteristic. For instance, by having carboxylic groups, carbomers can participate in hydrogen bonding with mucin [40,56]. Polyamidoamine dendrimer (PAMAM G3) has been used for coating the liposome with the aim of posterior eye drug delivery.

    • Doe guided chitosan based nano-ophthalmic preparation against fungal keratitis

      2020, Materials Today: Proceedings
      Citation Excerpt :

      Among the three formulations, high molecular weight chitosan (hmw) nanoparticles (NPs) shows high absorbance values which indicates their high adhesion capacity with mucin, followed by medium molecular weight chitosan (mmw) NPs and low molecular weight (lmw) NPs as the increase in chitosan molecular weight results in an increase number of positively charged units which shows stronger interactions with a negatively charged mucin particles [33]. Therefore, the increased interaction of Chitosan with mucin suggest the greater retention of the CANs on the mucous membrane of an eye [33–35]. The in-vitro drug release of an optimized CANs, high; medium; low formulations [each containing 1% API (w/v)] are presented in Fig. 7.

    • Comparison of response surface methodology and artificial neural network to optimize novel ophthalmic flexible nano-liposomes: Characterization, evaluation, in vivo pharmacokinetics and molecular dynamics simulation

      2018, Colloids and Surfaces B: Biointerfaces
      Citation Excerpt :

      Therefore, the retention time of the drug on the cornea was prolonged. In addition, Durrani et al. [51] have confirmed that PN liposome can enhance the penetration of PN in the cornea. In conclusion, the results demonstrated that PN-FLs have sustainable retention in the pre-cornea, offering long-lasting action and improving drug permeability and thus increasing the bioavailability of PN.

    View all citing articles on Scopus
    1

    Present address: School of Pharmacy, University of Otago, PO Box 913, Dunedin, New Zealand.

    View full text